news LMTK3 inhibitors could be an effective breast cancer therapy, say scientists 16 November 2020 | By Hannah Balfour (Drug Target Review) Researchers demonstrate that inhibiting the LMTK3 kinase is an effective anticancer strategy in murine models of breast cancer.